Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients. (Record no. 28511976)

MARC details
000 -LEADER
fixed length control field 02367 a2200625 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517222316.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201811s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1873-264X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.jpba.2018.05.052
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Reis, Rafael
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20181108
245 00 - TITLE STATEMENT
Title Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of pharmaceutical and biomedical analysis
Date of publication, distribution, etc. Sep 2018
300 ## - PHYSICAL DESCRIPTION
Extent 174-183 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Validation Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Acrylamides
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Afatinib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aniline Compounds
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Non-Small-Cell Lung
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chromatography, High Pressure Liquid
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Crizotinib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Monitoring
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Stability
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element ErbB Receptors
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Erlotinib Hydrochloride
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Limit of Detection
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperazines
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridines
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinazolines
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Vascular Endothelial Growth Factor
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Reproducibility of Results
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sensitivity and Specificity
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tandem Mass Spectrometry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Labat, Laurence
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Allard, Marie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boudou-Rouquette, Pascaline
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chapron, Jeanne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bellesoeur, Audrey
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thomas-Schoemann, Audrey
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arrondeau, Jennifer
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giraud, Frédérique
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Alexandre, Jérôme
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vidal, Michel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Goldwasser, François
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Blanchet, Benoît
773 0# - HOST ITEM ENTRY
Title Journal of pharmaceutical and biomedical analysis
Related parts vol. 158
-- p. 174-183
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.jpba.2018.05.052">https://doi.org/10.1016/j.jpba.2018.05.052</a>
Public note Available from publisher's website

No items available.